Plasticity and prospect of bone marrow derived liver stem cells

Zhang SH,Liao CX

DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.11.047

2007-01-01

Abstract:OBJECTIVE: Bone marrow stem cells can differentiate into other cells or tissue. This plastic phenomenon is also found in liver tissue. To summarize the source and occurrence of hepatic stem cells in the bone marrow, and explore its progress in this field and the clinical application. DATA SOURCES: A compute-base search of article about hepatic stem cell between January 1990 and June 2006 was conduct in PUBMED with the of "stem cell, hepatic" in English. At the same time, China Journal Full-text Database (CJFD) was searched with the same key words from January 1990 to June 2006 in Chinese. STUDY SELECTION: Articles were selected firstly, and each quotation was looked over. Inclusive criteria: the literatures related to the hepatic stem cells. Exclusive criteria: articles of repetitive research or Meta analysis. DATA EXTRACTION: A total of 231 related articles were retrieved, and 31 of them met with the inclusive criteria, while 200 old or repetitive studies were excluded, and 31 were about isolation, identification, application of hepatic stem cells and the mechanism and regulatory factors of migration and differentiation. DATA SYNTHESIS: Recent studies had verified that hepatic precursor cells indeed existed in the bone marrow. These cells not only could settle in the liver, but also differentiate into liver cells or biliary cells. This kind of cells was named bone marrow derived liver stem cells(BMDLSC) in literatures. Hematopoietic stem cells in bone marrow such as CD34 (+), C1qR (+), CD133 (+), C-kit (+), Thy1 (+), Sca-1 (+) contained BMDLSC subgroups. However, in vitro amplification or the surface molecules properties had not been reported. Lately, c-kit+Lin- (CD117) bone marrow cells, namely BMDLSC, were found well in the radioactive mouse. When the surface's molecules were founded, we could purify directly from the bone marrow cells and then transplante into the patient's liver. Not only could recover the number of liver cells due to lesion, but also repair organizational structure to achieve the same purpose of liver transplantation without rejection. CONCLUSION: At present, the treatment of liver cirrhosis and other diseases, transplant is the best way. However, due to the lack of donor and transplant rejection, the clinical application is limited. In contrast, stem cell transplantation is not only a wide variety of sources, but also little traumatic when transplant and the immune rejection is far less than liver transplant. It also can be used in liver disease of advanced stage and severe liver disease with bright prospect.